First, we analyzed cytokine secretion of MS patients and healthy donors and found that although IFN-γ secretion was predominant in both, IL-17 secretion was significantly increased in MS patients, as can be seen when the ratio of IFN-γ to IL-17 is presented. This evidence concerns the gene IFNG and myeloid sarcoma.